nodes	percent_of_prediction	percent_of_DWPC	metapath
Amitriptyline—NTRK2—peripheral nervous system neoplasm	0.342	0.587	CbGaD
Amitriptyline—NTRK1—peripheral nervous system neoplasm	0.211	0.363	CbGaD
Amitriptyline—ABCB1—peripheral nervous system neoplasm	0.0296	0.0508	CbGaD
Amitriptyline—CYP2B6—Tretinoin—peripheral nervous system neoplasm	0.0191	0.0897	CbGbCtD
Amitriptyline—CYP2E1—Dacarbazine—peripheral nervous system neoplasm	0.0166	0.0782	CbGbCtD
Amitriptyline—CYP3A5—Tretinoin—peripheral nervous system neoplasm	0.015	0.0707	CbGbCtD
Amitriptyline—CYP2C8—Tretinoin—peripheral nervous system neoplasm	0.0144	0.068	CbGbCtD
Amitriptyline—CYP1A2—Alitretinoin—peripheral nervous system neoplasm	0.012	0.0566	CbGbCtD
Amitriptyline—ABCB1—Topotecan—peripheral nervous system neoplasm	0.0105	0.0495	CbGbCtD
Amitriptyline—ABCB1—Alitretinoin—peripheral nervous system neoplasm	0.0105	0.0495	CbGbCtD
Amitriptyline—CYP2C9—Tretinoin—peripheral nervous system neoplasm	0.0101	0.0474	CbGbCtD
Amitriptyline—CYP1A2—Dacarbazine—peripheral nervous system neoplasm	0.00961	0.0452	CbGbCtD
Amitriptyline—CYP2B6—Cisplatin—peripheral nervous system neoplasm	0.00816	0.0384	CbGbCtD
Amitriptyline—CYP2E1—Etoposide—peripheral nervous system neoplasm	0.00813	0.0383	CbGbCtD
Amitriptyline—ABCB1—Dactinomycin—peripheral nervous system neoplasm	0.00728	0.0343	CbGbCtD
Amitriptyline—CYP3A5—Vincristine—peripheral nervous system neoplasm	0.00689	0.0325	CbGbCtD
Amitriptyline—CYP3A5—Etoposide—peripheral nervous system neoplasm	0.00632	0.0297	CbGbCtD
Amitriptyline—CYP3A4—Topotecan—peripheral nervous system neoplasm	0.0063	0.0296	CbGbCtD
Amitriptyline—CYP2C8—Etoposide—peripheral nervous system neoplasm	0.00607	0.0286	CbGbCtD
Amitriptyline—CYP3A4—Tretinoin—peripheral nervous system neoplasm	0.00585	0.0276	CbGbCtD
Amitriptyline—CYP2B6—Doxorubicin—peripheral nervous system neoplasm	0.00547	0.0258	CbGbCtD
Amitriptyline—CYP1A2—Etoposide—peripheral nervous system neoplasm	0.0047	0.0221	CbGbCtD
Amitriptyline—ABCB1—Vincristine—peripheral nervous system neoplasm	0.00449	0.0211	CbGbCtD
Amitriptyline—CYP2C9—Cisplatin—peripheral nervous system neoplasm	0.00431	0.0203	CbGbCtD
Amitriptyline—HTR1D—meninx—peripheral nervous system neoplasm	0.00421	0.0783	CbGeAlD
Amitriptyline—ABCB1—Cisplatin—peripheral nervous system neoplasm	0.00418	0.0197	CbGbCtD
Amitriptyline—ABCB1—Etoposide—peripheral nervous system neoplasm	0.00411	0.0194	CbGbCtD
Amitriptyline—HTR1B—dura mater—peripheral nervous system neoplasm	0.004	0.0744	CbGeAlD
Amitriptyline—HTR1D—dura mater—peripheral nervous system neoplasm	0.00388	0.072	CbGeAlD
Amitriptyline—ABCB1—Doxorubicin—peripheral nervous system neoplasm	0.0028	0.0132	CbGbCtD
Amitriptyline—CYP3A4—Vincristine—peripheral nervous system neoplasm	0.00269	0.0127	CbGbCtD
Amitriptyline—CYP2D6—Doxorubicin—peripheral nervous system neoplasm	0.00264	0.0124	CbGbCtD
Amitriptyline—CYP3A4—Etoposide—peripheral nervous system neoplasm	0.00246	0.0116	CbGbCtD
Amitriptyline—HTR2A—phrenic nerve—peripheral nervous system neoplasm	0.00226	0.0421	CbGeAlD
Amitriptyline—NTRK2—nerve—peripheral nervous system neoplasm	0.00212	0.0395	CbGeAlD
Amitriptyline—NTRK2—ganglion—peripheral nervous system neoplasm	0.0021	0.039	CbGeAlD
Amitriptyline—HTR1B—trigeminal nerve—peripheral nervous system neoplasm	0.00172	0.032	CbGeAlD
Amitriptyline—CYP3A4—Doxorubicin—peripheral nervous system neoplasm	0.00168	0.00791	CbGbCtD
Amitriptyline—HTR1D—trigeminal nerve—peripheral nervous system neoplasm	0.00167	0.031	CbGeAlD
Amitriptyline—NTRK1—trigeminal ganglion—peripheral nervous system neoplasm	0.00135	0.025	CbGeAlD
Amitriptyline—HTR7—vagus nerve—peripheral nervous system neoplasm	0.00124	0.0231	CbGeAlD
Amitriptyline—KCNA1—nerve—peripheral nervous system neoplasm	0.00123	0.0228	CbGeAlD
Amitriptyline—HTR1B—cranial nerve—peripheral nervous system neoplasm	0.00123	0.0228	CbGeAlD
Amitriptyline—HTR1D—cranial nerve—peripheral nervous system neoplasm	0.00119	0.0221	CbGeAlD
Amitriptyline—HTR6—ganglion—peripheral nervous system neoplasm	0.00103	0.0191	CbGeAlD
Amitriptyline—OPRD1—ganglion—peripheral nervous system neoplasm	0.000994	0.0185	CbGeAlD
Amitriptyline—HTR7—cranial nerve—peripheral nervous system neoplasm	0.000946	0.0176	CbGeAlD
Amitriptyline—HTR7—pons—peripheral nervous system neoplasm	0.000934	0.0174	CbGeAlD
Amitriptyline—NTRK2—brainstem—peripheral nervous system neoplasm	0.000912	0.0169	CbGeAlD
Amitriptyline—HTR2A—trigeminal nerve—peripheral nervous system neoplasm	0.000828	0.0154	CbGeAlD
Amitriptyline—HTR2A—vagus nerve—peripheral nervous system neoplasm	0.000774	0.0144	CbGeAlD
Amitriptyline—OPRM1—nerve—peripheral nervous system neoplasm	0.000687	0.0128	CbGeAlD
Amitriptyline—OPRM1—ganglion—peripheral nervous system neoplasm	0.000678	0.0126	CbGeAlD
Amitriptyline—KCNQ2—brainstem—peripheral nervous system neoplasm	0.000636	0.0118	CbGeAlD
Amitriptyline—HTR1B—ganglion—peripheral nervous system neoplasm	0.000621	0.0115	CbGeAlD
Amitriptyline—KCND2—brainstem—peripheral nervous system neoplasm	0.000602	0.0112	CbGeAlD
Amitriptyline—HTR1D—ganglion—peripheral nervous system neoplasm	0.000601	0.0112	CbGeAlD
Amitriptyline—KCNA1—trigeminal ganglion—peripheral nervous system neoplasm	0.000596	0.0111	CbGeAlD
Amitriptyline—HTR2C—ganglion—peripheral nervous system neoplasm	0.000595	0.0111	CbGeAlD
Amitriptyline—HTR2A—cranial nerve—peripheral nervous system neoplasm	0.00059	0.011	CbGeAlD
Amitriptyline—HTR2A—pons—peripheral nervous system neoplasm	0.000583	0.0108	CbGeAlD
Amitriptyline—SLC6A4—ganglion—peripheral nervous system neoplasm	0.000564	0.0105	CbGeAlD
Amitriptyline—KCNA1—brainstem—peripheral nervous system neoplasm	0.000528	0.00981	CbGeAlD
Amitriptyline—KCND3—brainstem—peripheral nervous system neoplasm	0.000525	0.00976	CbGeAlD
Amitriptyline—SLC6A2—nerve—peripheral nervous system neoplasm	0.000503	0.00935	CbGeAlD
Amitriptyline—HTR1A—ganglion—peripheral nervous system neoplasm	0.000501	0.00931	CbGeAlD
Amitriptyline—SLC6A2—ganglion—peripheral nervous system neoplasm	0.000497	0.00923	CbGeAlD
Amitriptyline—HTR7—nerve—peripheral nervous system neoplasm	0.000485	0.00901	CbGeAlD
Amitriptyline—HTR7—ganglion—peripheral nervous system neoplasm	0.000479	0.0089	CbGeAlD
Amitriptyline—DRD2—nerve—peripheral nervous system neoplasm	0.000458	0.00852	CbGeAlD
Amitriptyline—DRD2—ganglion—peripheral nervous system neoplasm	0.000453	0.00841	CbGeAlD
Amitriptyline—NTRK2—cerebellum—peripheral nervous system neoplasm	0.00045	0.00835	CbGeAlD
Amitriptyline—KCNQ3—cerebellum—peripheral nervous system neoplasm	0.000341	0.00633	CbGeAlD
Amitriptyline—KCNQ2—cerebellum—peripheral nervous system neoplasm	0.000314	0.00583	CbGeAlD
Amitriptyline—HTR1B—trigeminal ganglion—peripheral nervous system neoplasm	0.000305	0.00567	CbGeAlD
Amitriptyline—HTR2A—nerve—peripheral nervous system neoplasm	0.000302	0.00562	CbGeAlD
Amitriptyline—HTR2A—ganglion—peripheral nervous system neoplasm	0.000298	0.00555	CbGeAlD
Amitriptyline—KCND2—cerebellum—peripheral nervous system neoplasm	0.000297	0.00552	CbGeAlD
Amitriptyline—HTR1D—trigeminal ganglion—peripheral nervous system neoplasm	0.000295	0.00549	CbGeAlD
Amitriptyline—OPRM1—brainstem—peripheral nervous system neoplasm	0.000295	0.00548	CbGeAlD
Amitriptyline—SIGMAR1—trigeminal ganglion—peripheral nervous system neoplasm	0.000275	0.00511	CbGeAlD
Amitriptyline—HTR1B—brainstem—peripheral nervous system neoplasm	0.00027	0.00501	CbGeAlD
Amitriptyline—HTR1D—brainstem—peripheral nervous system neoplasm	0.000261	0.00485	CbGeAlD
Amitriptyline—CHRM1—parotid gland—peripheral nervous system neoplasm	0.00026	0.00484	CbGeAlD
Amitriptyline—KCNA1—cerebellum—peripheral nervous system neoplasm	0.00026	0.00484	CbGeAlD
Amitriptyline—SIGMAR1—parotid gland—peripheral nervous system neoplasm	0.00026	0.00482	CbGeAlD
Amitriptyline—KCND3—cerebellum—peripheral nervous system neoplasm	0.000259	0.00481	CbGeAlD
Amitriptyline—HTR2C—brainstem—peripheral nervous system neoplasm	0.000259	0.00481	CbGeAlD
Amitriptyline—SLC6A4—brainstem—peripheral nervous system neoplasm	0.000245	0.00456	CbGeAlD
Amitriptyline—HTR1A—brainstem—peripheral nervous system neoplasm	0.000218	0.00405	CbGeAlD
Amitriptyline—SLC6A2—brainstem—peripheral nervous system neoplasm	0.000216	0.00401	CbGeAlD
Amitriptyline—HTR7—brainstem—peripheral nervous system neoplasm	0.000208	0.00387	CbGeAlD
Amitriptyline—OPRK1—cerebellum—peripheral nervous system neoplasm	0.000204	0.0038	CbGeAlD
Amitriptyline—ADRA1A—brainstem—peripheral nervous system neoplasm	0.000201	0.00373	CbGeAlD
Amitriptyline—DRD2—brainstem—peripheral nervous system neoplasm	0.000197	0.00366	CbGeAlD
Amitriptyline—HRH1—trigeminal ganglion—peripheral nervous system neoplasm	0.000176	0.00326	CbGeAlD
Amitriptyline—ADRA2A—trigeminal ganglion—peripheral nervous system neoplasm	0.000172	0.0032	CbGeAlD
Amitriptyline—HTR2A—brainstem—peripheral nervous system neoplasm	0.00013	0.00241	CbGeAlD
Amitriptyline—SIGMAR1—cerebellum—peripheral nervous system neoplasm	0.00012	0.00223	CbGeAlD
Amitriptyline—Pruritus—Topotecan—peripheral nervous system neoplasm	0.000118	0.00139	CcSEcCtD
Amitriptyline—CYP2D6—brainstem—peripheral nervous system neoplasm	0.000118	0.0022	CbGeAlD
Amitriptyline—Decreased appetite—Dactinomycin—peripheral nervous system neoplasm	0.000118	0.00138	CcSEcCtD
Amitriptyline—Dysgeusia—Etoposide—peripheral nervous system neoplasm	0.000118	0.00138	CcSEcCtD
Amitriptyline—Leukopenia—Cisplatin—peripheral nervous system neoplasm	0.000118	0.00138	CcSEcCtD
Amitriptyline—Asthenia—Melphalan—peripheral nervous system neoplasm	0.000118	0.00138	CcSEcCtD
Amitriptyline—Hypotension—Alitretinoin—peripheral nervous system neoplasm	0.000118	0.00138	CcSEcCtD
Amitriptyline—Pruritus—Tretinoin—peripheral nervous system neoplasm	0.000117	0.00137	CcSEcCtD
Amitriptyline—Pruritus—Isotretinoin—peripheral nervous system neoplasm	0.000117	0.00137	CcSEcCtD
Amitriptyline—Hyperhidrosis—Vincristine—peripheral nervous system neoplasm	0.000117	0.00137	CcSEcCtD
Amitriptyline—Fatigue—Dactinomycin—peripheral nervous system neoplasm	0.000117	0.00137	CcSEcCtD
Amitriptyline—Purpura—Epirubicin—peripheral nervous system neoplasm	0.000116	0.00136	CcSEcCtD
Amitriptyline—Pruritus—Melphalan—peripheral nervous system neoplasm	0.000116	0.00136	CcSEcCtD
Amitriptyline—Vascular purpura—Doxorubicin—peripheral nervous system neoplasm	0.000116	0.00136	CcSEcCtD
Amitriptyline—Anorexia—Vincristine—peripheral nervous system neoplasm	0.000116	0.00135	CcSEcCtD
Amitriptyline—Hepatic failure—Doxorubicin—peripheral nervous system neoplasm	0.000115	0.00135	CcSEcCtD
Amitriptyline—Diarrhoea—Topotecan—peripheral nervous system neoplasm	0.000115	0.00134	CcSEcCtD
Amitriptyline—Cerebrovascular accident—Epirubicin—peripheral nervous system neoplasm	0.000114	0.00134	CcSEcCtD
Amitriptyline—Convulsion—Cisplatin—peripheral nervous system neoplasm	0.000114	0.00133	CcSEcCtD
Amitriptyline—Insomnia—Alitretinoin—peripheral nervous system neoplasm	0.000114	0.00133	CcSEcCtD
Amitriptyline—Diarrhoea—Tretinoin—peripheral nervous system neoplasm	0.000114	0.00133	CcSEcCtD
Amitriptyline—Diarrhoea—Isotretinoin—peripheral nervous system neoplasm	0.000114	0.00133	CcSEcCtD
Amitriptyline—Hypotension—Vincristine—peripheral nervous system neoplasm	0.000113	0.00133	CcSEcCtD
Amitriptyline—Paraesthesia—Alitretinoin—peripheral nervous system neoplasm	0.000113	0.00132	CcSEcCtD
Amitriptyline—Diarrhoea—Melphalan—peripheral nervous system neoplasm	0.000112	0.00131	CcSEcCtD
Amitriptyline—Osteoarthritis—Epirubicin—peripheral nervous system neoplasm	0.000112	0.00131	CcSEcCtD
Amitriptyline—Somnolence—Alitretinoin—peripheral nervous system neoplasm	0.000112	0.00131	CcSEcCtD
Amitriptyline—Feeling abnormal—Dactinomycin—peripheral nervous system neoplasm	0.000112	0.00131	CcSEcCtD
Amitriptyline—Ill-defined disorder—Etoposide—peripheral nervous system neoplasm	0.000112	0.00131	CcSEcCtD
Amitriptyline—Anxiety—Cisplatin—peripheral nervous system neoplasm	0.000111	0.0013	CcSEcCtD
Amitriptyline—Dyspepsia—Alitretinoin—peripheral nervous system neoplasm	0.000111	0.0013	CcSEcCtD
Amitriptyline—Dizziness—Topotecan—peripheral nervous system neoplasm	0.000111	0.0013	CcSEcCtD
Amitriptyline—Discomfort—Cisplatin—peripheral nervous system neoplasm	0.000111	0.00129	CcSEcCtD
Amitriptyline—Dizziness—Tretinoin—peripheral nervous system neoplasm	0.00011	0.00128	CcSEcCtD
Amitriptyline—Dizziness—Isotretinoin—peripheral nervous system neoplasm	0.00011	0.00128	CcSEcCtD
Amitriptyline—Insomnia—Vincristine—peripheral nervous system neoplasm	0.00011	0.00128	CcSEcCtD
Amitriptyline—Decreased appetite—Alitretinoin—peripheral nervous system neoplasm	0.000109	0.00128	CcSEcCtD
Amitriptyline—Paraesthesia—Vincristine—peripheral nervous system neoplasm	0.000109	0.00127	CcSEcCtD
Amitriptyline—Malaise—Etoposide—peripheral nervous system neoplasm	0.000109	0.00127	CcSEcCtD
Amitriptyline—Fatigue—Alitretinoin—peripheral nervous system neoplasm	0.000109	0.00127	CcSEcCtD
Amitriptyline—Leukopenia—Etoposide—peripheral nervous system neoplasm	0.000108	0.00126	CcSEcCtD
Amitriptyline—Constipation—Alitretinoin—peripheral nervous system neoplasm	0.000108	0.00126	CcSEcCtD
Amitriptyline—Purpura—Doxorubicin—peripheral nervous system neoplasm	0.000108	0.00126	CcSEcCtD
Amitriptyline—HTR1A—cerebellum—peripheral nervous system neoplasm	0.000107	0.00199	CbGeAlD
Amitriptyline—Body temperature increased—Dactinomycin—peripheral nervous system neoplasm	0.000107	0.00126	CcSEcCtD
Amitriptyline—Oedema—Cisplatin—peripheral nervous system neoplasm	0.000107	0.00125	CcSEcCtD
Amitriptyline—Vomiting—Topotecan—peripheral nervous system neoplasm	0.000106	0.00125	CcSEcCtD
Amitriptyline—Loss of consciousness—Etoposide—peripheral nervous system neoplasm	0.000106	0.00124	CcSEcCtD
Amitriptyline—Cerebrovascular accident—Doxorubicin—peripheral nervous system neoplasm	0.000106	0.00124	CcSEcCtD
Amitriptyline—Vomiting—Isotretinoin—peripheral nervous system neoplasm	0.000106	0.00124	CcSEcCtD
Amitriptyline—Vomiting—Tretinoin—peripheral nervous system neoplasm	0.000106	0.00124	CcSEcCtD
Amitriptyline—Rash—Topotecan—peripheral nervous system neoplasm	0.000106	0.00124	CcSEcCtD
Amitriptyline—Dermatitis—Topotecan—peripheral nervous system neoplasm	0.000105	0.00123	CcSEcCtD
Amitriptyline—Decreased appetite—Vincristine—peripheral nervous system neoplasm	0.000105	0.00123	CcSEcCtD
Amitriptyline—Ataxia—Epirubicin—peripheral nervous system neoplasm	0.000105	0.00123	CcSEcCtD
Amitriptyline—Thrombocytopenia—Cisplatin—peripheral nervous system neoplasm	0.000105	0.00123	CcSEcCtD
Amitriptyline—Headache—Topotecan—peripheral nervous system neoplasm	0.000105	0.00123	CcSEcCtD
Amitriptyline—Rash—Tretinoin—peripheral nervous system neoplasm	0.000105	0.00123	CcSEcCtD
Amitriptyline—Rash—Isotretinoin—peripheral nervous system neoplasm	0.000105	0.00123	CcSEcCtD
Amitriptyline—Tachycardia—Cisplatin—peripheral nervous system neoplasm	0.000105	0.00122	CcSEcCtD
Amitriptyline—Dermatitis—Tretinoin—peripheral nervous system neoplasm	0.000105	0.00122	CcSEcCtD
Amitriptyline—Dermatitis—Isotretinoin—peripheral nervous system neoplasm	0.000105	0.00122	CcSEcCtD
Amitriptyline—Fatigue—Vincristine—peripheral nervous system neoplasm	0.000105	0.00122	CcSEcCtD
Amitriptyline—Convulsion—Etoposide—peripheral nervous system neoplasm	0.000104	0.00122	CcSEcCtD
Amitriptyline—Vomiting—Melphalan—peripheral nervous system neoplasm	0.000104	0.00122	CcSEcCtD
Amitriptyline—Headache—Isotretinoin—peripheral nervous system neoplasm	0.000104	0.00122	CcSEcCtD
Amitriptyline—Headache—Tretinoin—peripheral nervous system neoplasm	0.000104	0.00122	CcSEcCtD
Amitriptyline—Hypertension—Etoposide—peripheral nervous system neoplasm	0.000104	0.00122	CcSEcCtD
Amitriptyline—Feeling abnormal—Alitretinoin—peripheral nervous system neoplasm	0.000104	0.00121	CcSEcCtD
Amitriptyline—Constipation—Vincristine—peripheral nervous system neoplasm	0.000104	0.00121	CcSEcCtD
Amitriptyline—Osteoarthritis—Doxorubicin—peripheral nervous system neoplasm	0.000104	0.00121	CcSEcCtD
Amitriptyline—Hyperhidrosis—Cisplatin—peripheral nervous system neoplasm	0.000104	0.00121	CcSEcCtD
Amitriptyline—Rash—Melphalan—peripheral nervous system neoplasm	0.000103	0.00121	CcSEcCtD
Amitriptyline—Dermatitis—Melphalan—peripheral nervous system neoplasm	0.000103	0.00121	CcSEcCtD
Amitriptyline—HTR7—cerebellum—peripheral nervous system neoplasm	0.000103	0.00191	CbGeAlD
Amitriptyline—Orthostatic hypotension—Epirubicin—peripheral nervous system neoplasm	0.000102	0.0012	CcSEcCtD
Amitriptyline—Anorexia—Cisplatin—peripheral nervous system neoplasm	0.000102	0.0012	CcSEcCtD
Amitriptyline—Discomfort—Etoposide—peripheral nervous system neoplasm	0.000101	0.00118	CcSEcCtD
Amitriptyline—Hypotension—Cisplatin—peripheral nervous system neoplasm	0.0001	0.00117	CcSEcCtD
Amitriptyline—Urticaria—Alitretinoin—peripheral nervous system neoplasm	0.0001	0.00117	CcSEcCtD
Amitriptyline—Body temperature increased—Alitretinoin—peripheral nervous system neoplasm	9.95e-05	0.00116	CcSEcCtD
Amitriptyline—Nausea—Topotecan—peripheral nervous system neoplasm	9.94e-05	0.00116	CcSEcCtD
Amitriptyline—Confusional state—Etoposide—peripheral nervous system neoplasm	9.91e-05	0.00116	CcSEcCtD
Amitriptyline—ADRA1A—cerebellum—peripheral nervous system neoplasm	9.89e-05	0.00184	CbGeAlD
Amitriptyline—Nausea—Isotretinoin—peripheral nervous system neoplasm	9.86e-05	0.00115	CcSEcCtD
Amitriptyline—Nausea—Tretinoin—peripheral nervous system neoplasm	9.86e-05	0.00115	CcSEcCtD
Amitriptyline—Ataxia—Doxorubicin—peripheral nervous system neoplasm	9.75e-05	0.00114	CcSEcCtD
Amitriptyline—Asthenia—Dactinomycin—peripheral nervous system neoplasm	9.74e-05	0.00114	CcSEcCtD
Amitriptyline—Nausea—Melphalan—peripheral nervous system neoplasm	9.74e-05	0.00114	CcSEcCtD
Amitriptyline—DRD2—cerebellum—peripheral nervous system neoplasm	9.7e-05	0.0018	CbGeAlD
Amitriptyline—Paraesthesia—Cisplatin—peripheral nervous system neoplasm	9.63e-05	0.00113	CcSEcCtD
Amitriptyline—Thrombocytopenia—Etoposide—peripheral nervous system neoplasm	9.62e-05	0.00113	CcSEcCtD
Amitriptyline—ABCB1—trigeminal ganglion—peripheral nervous system neoplasm	9.61e-05	0.00179	CbGeAlD
Amitriptyline—Tachycardia—Etoposide—peripheral nervous system neoplasm	9.59e-05	0.00112	CcSEcCtD
Amitriptyline—Eosinophilia—Epirubicin—peripheral nervous system neoplasm	9.59e-05	0.00112	CcSEcCtD
Amitriptyline—Body temperature increased—Vincristine—peripheral nervous system neoplasm	9.59e-05	0.00112	CcSEcCtD
Amitriptyline—Hyperhidrosis—Etoposide—peripheral nervous system neoplasm	9.5e-05	0.00111	CcSEcCtD
Amitriptyline—Orthostatic hypotension—Doxorubicin—peripheral nervous system neoplasm	9.47e-05	0.00111	CcSEcCtD
Amitriptyline—Anorexia—Etoposide—peripheral nervous system neoplasm	9.36e-05	0.0011	CcSEcCtD
Amitriptyline—Decreased appetite—Cisplatin—peripheral nervous system neoplasm	9.32e-05	0.00109	CcSEcCtD
Amitriptyline—Diarrhoea—Dactinomycin—peripheral nervous system neoplasm	9.29e-05	0.00109	CcSEcCtD
Amitriptyline—Pancytopenia—Epirubicin—peripheral nervous system neoplasm	9.2e-05	0.00108	CcSEcCtD
Amitriptyline—Hypotension—Etoposide—peripheral nervous system neoplasm	9.18e-05	0.00107	CcSEcCtD
Amitriptyline—Asthenia—Alitretinoin—peripheral nervous system neoplasm	9.03e-05	0.00106	CcSEcCtD
Amitriptyline—Pollakiuria—Epirubicin—peripheral nervous system neoplasm	8.95e-05	0.00105	CcSEcCtD
Amitriptyline—Pruritus—Alitretinoin—peripheral nervous system neoplasm	8.9e-05	0.00104	CcSEcCtD
Amitriptyline—Eosinophilia—Doxorubicin—peripheral nervous system neoplasm	8.87e-05	0.00104	CcSEcCtD
Amitriptyline—Feeling abnormal—Cisplatin—peripheral nervous system neoplasm	8.84e-05	0.00103	CcSEcCtD
Amitriptyline—Paraesthesia—Etoposide—peripheral nervous system neoplasm	8.82e-05	0.00103	CcSEcCtD
Amitriptyline—Weight increased—Epirubicin—peripheral nervous system neoplasm	8.81e-05	0.00103	CcSEcCtD
Amitriptyline—Somnolence—Etoposide—peripheral nervous system neoplasm	8.73e-05	0.00102	CcSEcCtD
Amitriptyline—Asthenia—Vincristine—peripheral nervous system neoplasm	8.7e-05	0.00102	CcSEcCtD
Amitriptyline—Drowsiness—Epirubicin—peripheral nervous system neoplasm	8.63e-05	0.00101	CcSEcCtD
Amitriptyline—Vomiting—Dactinomycin—peripheral nervous system neoplasm	8.63e-05	0.00101	CcSEcCtD
Amitriptyline—Diarrhoea—Alitretinoin—peripheral nervous system neoplasm	8.61e-05	0.00101	CcSEcCtD
Amitriptyline—Rash—Dactinomycin—peripheral nervous system neoplasm	8.56e-05	0.001	CcSEcCtD
Amitriptyline—Decreased appetite—Etoposide—peripheral nervous system neoplasm	8.54e-05	0.000999	CcSEcCtD
Amitriptyline—Pancytopenia—Doxorubicin—peripheral nervous system neoplasm	8.51e-05	0.000996	CcSEcCtD
Amitriptyline—Body temperature increased—Cisplatin—peripheral nervous system neoplasm	8.48e-05	0.000992	CcSEcCtD
Amitriptyline—Fatigue—Etoposide—peripheral nervous system neoplasm	8.47e-05	0.000991	CcSEcCtD
Amitriptyline—Neuropathy peripheral—Epirubicin—peripheral nervous system neoplasm	8.46e-05	0.00099	CcSEcCtD
Amitriptyline—Stomatitis—Epirubicin—peripheral nervous system neoplasm	8.42e-05	0.000985	CcSEcCtD
Amitriptyline—Jaundice—Epirubicin—peripheral nervous system neoplasm	8.42e-05	0.000985	CcSEcCtD
Amitriptyline—Constipation—Etoposide—peripheral nervous system neoplasm	8.4e-05	0.000983	CcSEcCtD
Amitriptyline—Dizziness—Alitretinoin—peripheral nervous system neoplasm	8.32e-05	0.000974	CcSEcCtD
Amitriptyline—Diarrhoea—Vincristine—peripheral nervous system neoplasm	8.3e-05	0.000971	CcSEcCtD
Amitriptyline—Pollakiuria—Doxorubicin—peripheral nervous system neoplasm	8.28e-05	0.000969	CcSEcCtD
Amitriptyline—Weight increased—Doxorubicin—peripheral nervous system neoplasm	8.15e-05	0.000954	CcSEcCtD
Amitriptyline—Feeling abnormal—Etoposide—peripheral nervous system neoplasm	8.1e-05	0.000947	CcSEcCtD
Amitriptyline—Nausea—Dactinomycin—peripheral nervous system neoplasm	8.06e-05	0.000943	CcSEcCtD
Amitriptyline—Agranulocytosis—Epirubicin—peripheral nervous system neoplasm	8.06e-05	0.000943	CcSEcCtD
Amitriptyline—Dizziness—Vincristine—peripheral nervous system neoplasm	8.02e-05	0.000938	CcSEcCtD
Amitriptyline—Vomiting—Alitretinoin—peripheral nervous system neoplasm	8e-05	0.000936	CcSEcCtD
Amitriptyline—Drowsiness—Doxorubicin—peripheral nervous system neoplasm	7.99e-05	0.000935	CcSEcCtD
Amitriptyline—Rash—Alitretinoin—peripheral nervous system neoplasm	7.94e-05	0.000929	CcSEcCtD
Amitriptyline—Dermatitis—Alitretinoin—peripheral nervous system neoplasm	7.93e-05	0.000928	CcSEcCtD
Amitriptyline—Headache—Alitretinoin—peripheral nervous system neoplasm	7.88e-05	0.000923	CcSEcCtD
Amitriptyline—Neuropathy peripheral—Doxorubicin—peripheral nervous system neoplasm	7.83e-05	0.000916	CcSEcCtD
Amitriptyline—Urticaria—Etoposide—peripheral nervous system neoplasm	7.8e-05	0.000913	CcSEcCtD
Amitriptyline—Jaundice—Doxorubicin—peripheral nervous system neoplasm	7.79e-05	0.000911	CcSEcCtD
Amitriptyline—Stomatitis—Doxorubicin—peripheral nervous system neoplasm	7.79e-05	0.000911	CcSEcCtD
Amitriptyline—Body temperature increased—Etoposide—peripheral nervous system neoplasm	7.77e-05	0.000909	CcSEcCtD
Amitriptyline—Hepatitis—Epirubicin—peripheral nervous system neoplasm	7.75e-05	0.000907	CcSEcCtD
Amitriptyline—Hypoaesthesia—Epirubicin—peripheral nervous system neoplasm	7.71e-05	0.000902	CcSEcCtD
Amitriptyline—Vomiting—Vincristine—peripheral nervous system neoplasm	7.71e-05	0.000902	CcSEcCtD
Amitriptyline—Asthenia—Cisplatin—peripheral nervous system neoplasm	7.69e-05	0.0009	CcSEcCtD
Amitriptyline—Rash—Vincristine—peripheral nervous system neoplasm	7.65e-05	0.000895	CcSEcCtD
Amitriptyline—Dermatitis—Vincristine—peripheral nervous system neoplasm	7.64e-05	0.000894	CcSEcCtD
Amitriptyline—Headache—Vincristine—peripheral nervous system neoplasm	7.6e-05	0.000889	CcSEcCtD
Amitriptyline—ADRA2A—cerebellum—peripheral nervous system neoplasm	7.52e-05	0.0014	CbGeAlD
Amitriptyline—Nausea—Alitretinoin—peripheral nervous system neoplasm	7.48e-05	0.000875	CcSEcCtD
Amitriptyline—Agranulocytosis—Doxorubicin—peripheral nervous system neoplasm	7.46e-05	0.000872	CcSEcCtD
Amitriptyline—CYP2E1—cerebellum—peripheral nervous system neoplasm	7.36e-05	0.00137	CbGeAlD
Amitriptyline—Diarrhoea—Cisplatin—peripheral nervous system neoplasm	7.34e-05	0.000859	CcSEcCtD
Amitriptyline—Tinnitus—Epirubicin—peripheral nervous system neoplasm	7.23e-05	0.000846	CcSEcCtD
Amitriptyline—Nausea—Vincristine—peripheral nervous system neoplasm	7.2e-05	0.000843	CcSEcCtD
Amitriptyline—Hepatitis—Doxorubicin—peripheral nervous system neoplasm	7.17e-05	0.000839	CcSEcCtD
Amitriptyline—Hypoaesthesia—Doxorubicin—peripheral nervous system neoplasm	7.14e-05	0.000835	CcSEcCtD
Amitriptyline—Asthenia—Etoposide—peripheral nervous system neoplasm	7.05e-05	0.000825	CcSEcCtD
Amitriptyline—Pruritus—Etoposide—peripheral nervous system neoplasm	6.95e-05	0.000813	CcSEcCtD
Amitriptyline—Arrhythmia—Epirubicin—peripheral nervous system neoplasm	6.92e-05	0.00081	CcSEcCtD
Amitriptyline—Alopecia—Epirubicin—peripheral nervous system neoplasm	6.85e-05	0.000801	CcSEcCtD
Amitriptyline—Vomiting—Cisplatin—peripheral nervous system neoplasm	6.82e-05	0.000798	CcSEcCtD
Amitriptyline—Rash—Cisplatin—peripheral nervous system neoplasm	6.76e-05	0.000791	CcSEcCtD
Amitriptyline—Dermatitis—Cisplatin—peripheral nervous system neoplasm	6.75e-05	0.00079	CcSEcCtD
Amitriptyline—Diarrhoea—Etoposide—peripheral nervous system neoplasm	6.72e-05	0.000787	CcSEcCtD
Amitriptyline—Tinnitus—Doxorubicin—peripheral nervous system neoplasm	6.69e-05	0.000782	CcSEcCtD
Amitriptyline—Dysgeusia—Epirubicin—peripheral nervous system neoplasm	6.61e-05	0.000773	CcSEcCtD
Amitriptyline—Dizziness—Etoposide—peripheral nervous system neoplasm	6.5e-05	0.00076	CcSEcCtD
Amitriptyline—Arrhythmia—Doxorubicin—peripheral nervous system neoplasm	6.41e-05	0.00075	CcSEcCtD
Amitriptyline—HTR2A—cerebellum—peripheral nervous system neoplasm	6.4e-05	0.00119	CbGeAlD
Amitriptyline—Nausea—Cisplatin—peripheral nervous system neoplasm	6.37e-05	0.000745	CcSEcCtD
Amitriptyline—Vision blurred—Epirubicin—peripheral nervous system neoplasm	6.36e-05	0.000744	CcSEcCtD
Amitriptyline—Alopecia—Doxorubicin—peripheral nervous system neoplasm	6.34e-05	0.000742	CcSEcCtD
Amitriptyline—Epinastine—ABCB1—peripheral nervous system neoplasm	6.31e-05	0.235	CrCbGaD
Amitriptyline—Ill-defined disorder—Epirubicin—peripheral nervous system neoplasm	6.26e-05	0.000733	CcSEcCtD
Amitriptyline—Vomiting—Etoposide—peripheral nervous system neoplasm	6.25e-05	0.000731	CcSEcCtD
Amitriptyline—Agitation—Epirubicin—peripheral nervous system neoplasm	6.2e-05	0.000726	CcSEcCtD
Amitriptyline—Rash—Etoposide—peripheral nervous system neoplasm	6.19e-05	0.000725	CcSEcCtD
Amitriptyline—Dermatitis—Etoposide—peripheral nervous system neoplasm	6.19e-05	0.000724	CcSEcCtD
Amitriptyline—Headache—Etoposide—peripheral nervous system neoplasm	6.15e-05	0.00072	CcSEcCtD
Amitriptyline—Dysgeusia—Doxorubicin—peripheral nervous system neoplasm	6.11e-05	0.000715	CcSEcCtD
Amitriptyline—Malaise—Epirubicin—peripheral nervous system neoplasm	6.08e-05	0.000712	CcSEcCtD
Amitriptyline—Syncope—Epirubicin—peripheral nervous system neoplasm	6.05e-05	0.000708	CcSEcCtD
Amitriptyline—Leukopenia—Epirubicin—peripheral nervous system neoplasm	6.04e-05	0.000707	CcSEcCtD
Amitriptyline—Palpitations—Epirubicin—peripheral nervous system neoplasm	5.96e-05	0.000698	CcSEcCtD
Amitriptyline—Loss of consciousness—Epirubicin—peripheral nervous system neoplasm	5.93e-05	0.000694	CcSEcCtD
Amitriptyline—Vision blurred—Doxorubicin—peripheral nervous system neoplasm	5.88e-05	0.000688	CcSEcCtD
Amitriptyline—Convulsion—Epirubicin—peripheral nervous system neoplasm	5.85e-05	0.000684	CcSEcCtD
Amitriptyline—Nausea—Etoposide—peripheral nervous system neoplasm	5.84e-05	0.000683	CcSEcCtD
Amitriptyline—CYP2D6—cerebellum—peripheral nervous system neoplasm	5.83e-05	0.00108	CbGeAlD
Amitriptyline—Hypertension—Epirubicin—peripheral nervous system neoplasm	5.83e-05	0.000682	CcSEcCtD
Amitriptyline—Ill-defined disorder—Doxorubicin—peripheral nervous system neoplasm	5.79e-05	0.000678	CcSEcCtD
Amitriptyline—Agitation—Doxorubicin—peripheral nervous system neoplasm	5.74e-05	0.000671	CcSEcCtD
Amitriptyline—Anxiety—Epirubicin—peripheral nervous system neoplasm	5.72e-05	0.00067	CcSEcCtD
Amitriptyline—Discomfort—Epirubicin—peripheral nervous system neoplasm	5.68e-05	0.000664	CcSEcCtD
Amitriptyline—Malaise—Doxorubicin—peripheral nervous system neoplasm	5.63e-05	0.000659	CcSEcCtD
Amitriptyline—Dry mouth—Epirubicin—peripheral nervous system neoplasm	5.62e-05	0.000657	CcSEcCtD
Amitriptyline—Syncope—Doxorubicin—peripheral nervous system neoplasm	5.6e-05	0.000655	CcSEcCtD
Amitriptyline—Leukopenia—Doxorubicin—peripheral nervous system neoplasm	5.59e-05	0.000654	CcSEcCtD
Amitriptyline—Confusional state—Epirubicin—peripheral nervous system neoplasm	5.55e-05	0.00065	CcSEcCtD
Amitriptyline—Palpitations—Doxorubicin—peripheral nervous system neoplasm	5.52e-05	0.000646	CcSEcCtD
Amitriptyline—Oedema—Epirubicin—peripheral nervous system neoplasm	5.51e-05	0.000644	CcSEcCtD
Amitriptyline—Loss of consciousness—Doxorubicin—peripheral nervous system neoplasm	5.49e-05	0.000642	CcSEcCtD
Amitriptyline—Shock—Epirubicin—peripheral nervous system neoplasm	5.42e-05	0.000634	CcSEcCtD
Amitriptyline—Convulsion—Doxorubicin—peripheral nervous system neoplasm	5.41e-05	0.000633	CcSEcCtD
Amitriptyline—Thrombocytopenia—Epirubicin—peripheral nervous system neoplasm	5.39e-05	0.000631	CcSEcCtD
Amitriptyline—Hypertension—Doxorubicin—peripheral nervous system neoplasm	5.39e-05	0.000631	CcSEcCtD
Amitriptyline—Tachycardia—Epirubicin—peripheral nervous system neoplasm	5.37e-05	0.000629	CcSEcCtD
Amitriptyline—Hyperhidrosis—Epirubicin—peripheral nervous system neoplasm	5.32e-05	0.000623	CcSEcCtD
Amitriptyline—Anxiety—Doxorubicin—peripheral nervous system neoplasm	5.3e-05	0.00062	CcSEcCtD
Amitriptyline—Discomfort—Doxorubicin—peripheral nervous system neoplasm	5.25e-05	0.000614	CcSEcCtD
Amitriptyline—Anorexia—Epirubicin—peripheral nervous system neoplasm	5.25e-05	0.000614	CcSEcCtD
Amitriptyline—Dry mouth—Doxorubicin—peripheral nervous system neoplasm	5.2e-05	0.000608	CcSEcCtD
Amitriptyline—Hypotension—Epirubicin—peripheral nervous system neoplasm	5.15e-05	0.000602	CcSEcCtD
Amitriptyline—Confusional state—Doxorubicin—peripheral nervous system neoplasm	5.14e-05	0.000601	CcSEcCtD
Amitriptyline—Oedema—Doxorubicin—peripheral nervous system neoplasm	5.1e-05	0.000596	CcSEcCtD
Amitriptyline—Shock—Doxorubicin—peripheral nervous system neoplasm	5.01e-05	0.000587	CcSEcCtD
Amitriptyline—Thrombocytopenia—Doxorubicin—peripheral nervous system neoplasm	4.99e-05	0.000584	CcSEcCtD
Amitriptyline—Insomnia—Epirubicin—peripheral nervous system neoplasm	4.98e-05	0.000583	CcSEcCtD
Amitriptyline—Tachycardia—Doxorubicin—peripheral nervous system neoplasm	4.97e-05	0.000582	CcSEcCtD
Amitriptyline—Paraesthesia—Epirubicin—peripheral nervous system neoplasm	4.94e-05	0.000579	CcSEcCtD
Amitriptyline—Hyperhidrosis—Doxorubicin—peripheral nervous system neoplasm	4.93e-05	0.000576	CcSEcCtD
Amitriptyline—Somnolence—Epirubicin—peripheral nervous system neoplasm	4.9e-05	0.000573	CcSEcCtD
Amitriptyline—Anorexia—Doxorubicin—peripheral nervous system neoplasm	4.86e-05	0.000568	CcSEcCtD
Amitriptyline—Dyspepsia—Epirubicin—peripheral nervous system neoplasm	4.85e-05	0.000567	CcSEcCtD
Amitriptyline—Decreased appetite—Epirubicin—peripheral nervous system neoplasm	4.79e-05	0.00056	CcSEcCtD
Amitriptyline—Hypotension—Doxorubicin—peripheral nervous system neoplasm	4.76e-05	0.000557	CcSEcCtD
Amitriptyline—Fatigue—Epirubicin—peripheral nervous system neoplasm	4.75e-05	0.000556	CcSEcCtD
Amitriptyline—Constipation—Epirubicin—peripheral nervous system neoplasm	4.71e-05	0.000551	CcSEcCtD
Amitriptyline—Insomnia—Doxorubicin—peripheral nervous system neoplasm	4.61e-05	0.000539	CcSEcCtD
Amitriptyline—Paraesthesia—Doxorubicin—peripheral nervous system neoplasm	4.58e-05	0.000535	CcSEcCtD
Amitriptyline—Feeling abnormal—Epirubicin—peripheral nervous system neoplasm	4.54e-05	0.000531	CcSEcCtD
Amitriptyline—Somnolence—Doxorubicin—peripheral nervous system neoplasm	4.53e-05	0.00053	CcSEcCtD
Amitriptyline—Dyspepsia—Doxorubicin—peripheral nervous system neoplasm	4.49e-05	0.000525	CcSEcCtD
Amitriptyline—Decreased appetite—Doxorubicin—peripheral nervous system neoplasm	4.43e-05	0.000518	CcSEcCtD
Amitriptyline—Fatigue—Doxorubicin—peripheral nervous system neoplasm	4.39e-05	0.000514	CcSEcCtD
Amitriptyline—Urticaria—Epirubicin—peripheral nervous system neoplasm	4.37e-05	0.000512	CcSEcCtD
Amitriptyline—Constipation—Doxorubicin—peripheral nervous system neoplasm	4.36e-05	0.00051	CcSEcCtD
Amitriptyline—Body temperature increased—Epirubicin—peripheral nervous system neoplasm	4.35e-05	0.000509	CcSEcCtD
Amitriptyline—Feeling abnormal—Doxorubicin—peripheral nervous system neoplasm	4.2e-05	0.000491	CcSEcCtD
Amitriptyline—ABCB1—cerebellum—peripheral nervous system neoplasm	4.19e-05	0.000779	CbGeAlD
Amitriptyline—Urticaria—Doxorubicin—peripheral nervous system neoplasm	4.05e-05	0.000474	CcSEcCtD
Amitriptyline—Body temperature increased—Doxorubicin—peripheral nervous system neoplasm	4.03e-05	0.000471	CcSEcCtD
Amitriptyline—Asthenia—Epirubicin—peripheral nervous system neoplasm	3.95e-05	0.000462	CcSEcCtD
Amitriptyline—Pruritus—Epirubicin—peripheral nervous system neoplasm	3.9e-05	0.000456	CcSEcCtD
Amitriptyline—Diarrhoea—Epirubicin—peripheral nervous system neoplasm	3.77e-05	0.000441	CcSEcCtD
Amitriptyline—Asthenia—Doxorubicin—peripheral nervous system neoplasm	3.66e-05	0.000428	CcSEcCtD
Amitriptyline—Dizziness—Epirubicin—peripheral nervous system neoplasm	3.64e-05	0.000426	CcSEcCtD
Amitriptyline—Pruritus—Doxorubicin—peripheral nervous system neoplasm	3.6e-05	0.000422	CcSEcCtD
Amitriptyline—Vomiting—Epirubicin—peripheral nervous system neoplasm	3.5e-05	0.00041	CcSEcCtD
Amitriptyline—Diarrhoea—Doxorubicin—peripheral nervous system neoplasm	3.49e-05	0.000408	CcSEcCtD
Amitriptyline—Rash—Epirubicin—peripheral nervous system neoplasm	3.47e-05	0.000406	CcSEcCtD
Amitriptyline—Dermatitis—Epirubicin—peripheral nervous system neoplasm	3.47e-05	0.000406	CcSEcCtD
Amitriptyline—Headache—Epirubicin—peripheral nervous system neoplasm	3.45e-05	0.000404	CcSEcCtD
Amitriptyline—Dizziness—Doxorubicin—peripheral nervous system neoplasm	3.37e-05	0.000394	CcSEcCtD
Amitriptyline—Clomipramine—ABCB1—peripheral nervous system neoplasm	3.34e-05	0.124	CrCbGaD
Amitriptyline—Chlorprothixene—ABCB1—peripheral nervous system neoplasm	3.33e-05	0.124	CrCbGaD
Amitriptyline—Nausea—Epirubicin—peripheral nervous system neoplasm	3.27e-05	0.000383	CcSEcCtD
Amitriptyline—Vomiting—Doxorubicin—peripheral nervous system neoplasm	3.24e-05	0.000379	CcSEcCtD
Amitriptyline—Rash—Doxorubicin—peripheral nervous system neoplasm	3.21e-05	0.000376	CcSEcCtD
Amitriptyline—Dermatitis—Doxorubicin—peripheral nervous system neoplasm	3.21e-05	0.000376	CcSEcCtD
Amitriptyline—Headache—Doxorubicin—peripheral nervous system neoplasm	3.19e-05	0.000374	CcSEcCtD
Amitriptyline—Trimipramine—ABCB1—peripheral nervous system neoplasm	3.07e-05	0.114	CrCbGaD
Amitriptyline—Nausea—Doxorubicin—peripheral nervous system neoplasm	3.03e-05	0.000354	CcSEcCtD
Amitriptyline—Promethazine—ABCB1—peripheral nervous system neoplasm	2.96e-05	0.11	CrCbGaD
Amitriptyline—Doxepin—ABCB1—peripheral nervous system neoplasm	2.93e-05	0.109	CrCbGaD
Amitriptyline—Desipramine—ABCB1—peripheral nervous system neoplasm	2.69e-05	0.0999	CrCbGaD
Amitriptyline—Imipramine—ABCB1—peripheral nervous system neoplasm	2.28e-05	0.0847	CrCbGaD
Amitriptyline—HTR1B—GPCR downstream signaling—AKT1—peripheral nervous system neoplasm	3.42e-06	5.24e-05	CbGpPWpGaD
Amitriptyline—CHRM4—Signaling by GPCR—HRAS—peripheral nervous system neoplasm	3.41e-06	5.23e-05	CbGpPWpGaD
Amitriptyline—HTR1B—Signaling Pathways—CASP3—peripheral nervous system neoplasm	3.39e-06	5.19e-05	CbGpPWpGaD
Amitriptyline—CYP2C19—Metabolism—ABCB1—peripheral nervous system neoplasm	3.38e-06	5.18e-05	CbGpPWpGaD
Amitriptyline—OPRD1—Signaling Pathways—NRAS—peripheral nervous system neoplasm	3.38e-06	5.18e-05	CbGpPWpGaD
Amitriptyline—ABCB1—Metabolism—GNAS—peripheral nervous system neoplasm	3.37e-06	5.15e-05	CbGpPWpGaD
Amitriptyline—CYP1A2—Metabolism—SLC2A1—peripheral nervous system neoplasm	3.34e-06	5.11e-05	CbGpPWpGaD
Amitriptyline—CHRM4—GPCR downstream signaling—AKT1—peripheral nervous system neoplasm	3.32e-06	5.08e-05	CbGpPWpGaD
Amitriptyline—OPRM1—Signaling Pathways—ERBB2—peripheral nervous system neoplasm	3.29e-06	5.04e-05	CbGpPWpGaD
Amitriptyline—CYP1A2—Metabolism—TH—peripheral nervous system neoplasm	3.29e-06	5.04e-05	CbGpPWpGaD
Amitriptyline—CHRM4—Signaling Pathways—CASP3—peripheral nervous system neoplasm	3.29e-06	5.04e-05	CbGpPWpGaD
Amitriptyline—NTRK1—Signaling Pathways—HRAS—peripheral nervous system neoplasm	3.28e-06	5.02e-05	CbGpPWpGaD
Amitriptyline—CHRM5—Signaling by GPCR—HRAS—peripheral nervous system neoplasm	3.27e-06	5.01e-05	CbGpPWpGaD
Amitriptyline—ADRA1D—Signaling Pathways—ERBB2—peripheral nervous system neoplasm	3.26e-06	5e-05	CbGpPWpGaD
Amitriptyline—DRD3—Signaling Pathways—ERBB2—peripheral nervous system neoplasm	3.26e-06	5e-05	CbGpPWpGaD
Amitriptyline—OPRK1—Signaling by GPCR—AKT1—peripheral nervous system neoplasm	3.24e-06	4.97e-05	CbGpPWpGaD
Amitriptyline—ADRA2A—Hemostasis—AKT1—peripheral nervous system neoplasm	3.24e-06	4.96e-05	CbGpPWpGaD
Amitriptyline—DRD2—Signaling by GPCR—NRAS—peripheral nervous system neoplasm	3.22e-06	4.92e-05	CbGpPWpGaD
Amitriptyline—CYP3A4—Metabolism—ENO2—peripheral nervous system neoplasm	3.2e-06	4.9e-05	CbGpPWpGaD
Amitriptyline—HTR6—Signaling by GPCR—AKT1—peripheral nervous system neoplasm	3.2e-06	4.89e-05	CbGpPWpGaD
Amitriptyline—HTR7—Signaling by GPCR—AKT1—peripheral nervous system neoplasm	3.19e-06	4.89e-05	CbGpPWpGaD
Amitriptyline—CHRM5—GPCR downstream signaling—AKT1—peripheral nervous system neoplasm	3.18e-06	4.87e-05	CbGpPWpGaD
Amitriptyline—HRH4—Signaling Pathways—AKT1—peripheral nervous system neoplasm	3.18e-06	4.86e-05	CbGpPWpGaD
Amitriptyline—HTR1D—Signaling by GPCR—AKT1—peripheral nervous system neoplasm	3.17e-06	4.86e-05	CbGpPWpGaD
Amitriptyline—CYP2D6—Metabolism—GNAS—peripheral nervous system neoplasm	3.17e-06	4.86e-05	CbGpPWpGaD
Amitriptyline—HTR2A—Signaling by GPCR—NRAS—peripheral nervous system neoplasm	3.16e-06	4.84e-05	CbGpPWpGaD
Amitriptyline—DRD2—Signaling Pathways—PTPN11—peripheral nervous system neoplasm	3.16e-06	4.84e-05	CbGpPWpGaD
Amitriptyline—HRH1—Signaling by GPCR—NRAS—peripheral nervous system neoplasm	3.16e-06	4.83e-05	CbGpPWpGaD
Amitriptyline—OPRD1—Signaling Pathways—MYC—peripheral nervous system neoplasm	3.15e-06	4.82e-05	CbGpPWpGaD
Amitriptyline—CHRM5—Signaling Pathways—CASP3—peripheral nervous system neoplasm	3.15e-06	4.82e-05	CbGpPWpGaD
Amitriptyline—CHRM1—Signaling by GPCR—NRAS—peripheral nervous system neoplasm	3.15e-06	4.82e-05	CbGpPWpGaD
Amitriptyline—CYP2C9—Metabolism—GNAS—peripheral nervous system neoplasm	3.14e-06	4.81e-05	CbGpPWpGaD
Amitriptyline—CHRM3—Signaling by GPCR—NRAS—peripheral nervous system neoplasm	3.14e-06	4.8e-05	CbGpPWpGaD
Amitriptyline—CYP2D6—Metabolism—ABCB1—peripheral nervous system neoplasm	3.11e-06	4.77e-05	CbGpPWpGaD
Amitriptyline—HTR2A—Signaling Pathways—PTPN11—peripheral nervous system neoplasm	3.11e-06	4.76e-05	CbGpPWpGaD
Amitriptyline—CHRM2—Signaling by GPCR—NRAS—peripheral nervous system neoplasm	3.11e-06	4.76e-05	CbGpPWpGaD
Amitriptyline—HTR1B—Signaling by GPCR—AKT1—peripheral nervous system neoplasm	3.11e-06	4.76e-05	CbGpPWpGaD
Amitriptyline—OPRM1—Signaling by GPCR—HRAS—peripheral nervous system neoplasm	3.1e-06	4.75e-05	CbGpPWpGaD
Amitriptyline—HRH1—Signaling Pathways—PTPN11—peripheral nervous system neoplasm	3.1e-06	4.75e-05	CbGpPWpGaD
Amitriptyline—ADRA1A—Signaling by GPCR—NRAS—peripheral nervous system neoplasm	3.1e-06	4.74e-05	CbGpPWpGaD
Amitriptyline—CHRM1—Signaling Pathways—PTPN11—peripheral nervous system neoplasm	3.09e-06	4.73e-05	CbGpPWpGaD
Amitriptyline—CYP2C9—Metabolism—ABCB1—peripheral nervous system neoplasm	3.09e-06	4.72e-05	CbGpPWpGaD
Amitriptyline—CHRM3—Signaling Pathways—PTPN11—peripheral nervous system neoplasm	3.08e-06	4.72e-05	CbGpPWpGaD
Amitriptyline—ADRA1D—Signaling by GPCR—HRAS—peripheral nervous system neoplasm	3.07e-06	4.71e-05	CbGpPWpGaD
Amitriptyline—DRD3—Signaling by GPCR—HRAS—peripheral nervous system neoplasm	3.07e-06	4.71e-05	CbGpPWpGaD
Amitriptyline—CHRM2—Signaling Pathways—PTPN11—peripheral nervous system neoplasm	3.05e-06	4.67e-05	CbGpPWpGaD
Amitriptyline—ADRA1A—Signaling Pathways—PTPN11—peripheral nervous system neoplasm	3.04e-06	4.66e-05	CbGpPWpGaD
Amitriptyline—ALB—Hemostasis—TP53—peripheral nervous system neoplasm	3.03e-06	4.64e-05	CbGpPWpGaD
Amitriptyline—OPRM1—GPCR downstream signaling—AKT1—peripheral nervous system neoplasm	3.02e-06	4.62e-05	CbGpPWpGaD
Amitriptyline—CHRM4—Signaling by GPCR—AKT1—peripheral nervous system neoplasm	3.02e-06	4.62e-05	CbGpPWpGaD
Amitriptyline—OPRM1—Signaling Pathways—CASP3—peripheral nervous system neoplasm	2.99e-06	4.58e-05	CbGpPWpGaD
Amitriptyline—DRD3—GPCR downstream signaling—AKT1—peripheral nervous system neoplasm	2.99e-06	4.58e-05	CbGpPWpGaD
Amitriptyline—ADRA1D—GPCR downstream signaling—AKT1—peripheral nervous system neoplasm	2.99e-06	4.58e-05	CbGpPWpGaD
Amitriptyline—OPRK1—Signaling Pathways—NRAS—peripheral nervous system neoplasm	2.97e-06	4.54e-05	CbGpPWpGaD
Amitriptyline—ADRA1D—Signaling Pathways—CASP3—peripheral nervous system neoplasm	2.96e-06	4.54e-05	CbGpPWpGaD
Amitriptyline—DRD3—Signaling Pathways—CASP3—peripheral nervous system neoplasm	2.96e-06	4.54e-05	CbGpPWpGaD
Amitriptyline—HTR6—Signaling Pathways—NRAS—peripheral nervous system neoplasm	2.92e-06	4.48e-05	CbGpPWpGaD
Amitriptyline—HTR7—Signaling Pathways—NRAS—peripheral nervous system neoplasm	2.92e-06	4.47e-05	CbGpPWpGaD
Amitriptyline—HRH2—Signaling Pathways—TP53—peripheral nervous system neoplasm	2.92e-06	4.46e-05	CbGpPWpGaD
Amitriptyline—HTR1D—Signaling Pathways—NRAS—peripheral nervous system neoplasm	2.9e-06	4.44e-05	CbGpPWpGaD
Amitriptyline—ALB—Hemostasis—HRAS—peripheral nervous system neoplasm	2.9e-06	4.43e-05	CbGpPWpGaD
Amitriptyline—NTRK1—Signaling Pathways—AKT1—peripheral nervous system neoplasm	2.89e-06	4.43e-05	CbGpPWpGaD
Amitriptyline—CHRM5—Signaling by GPCR—AKT1—peripheral nervous system neoplasm	2.89e-06	4.42e-05	CbGpPWpGaD
Amitriptyline—ADRA2A—Signaling by GPCR—NRAS—peripheral nervous system neoplasm	2.88e-06	4.41e-05	CbGpPWpGaD
Amitriptyline—HTR1A—Signaling Pathways—ERBB2—peripheral nervous system neoplasm	2.84e-06	4.35e-05	CbGpPWpGaD
Amitriptyline—HTR1B—Signaling Pathways—NRAS—peripheral nervous system neoplasm	2.84e-06	4.35e-05	CbGpPWpGaD
Amitriptyline—HTR2C—Signaling Pathways—ERBB2—peripheral nervous system neoplasm	2.83e-06	4.33e-05	CbGpPWpGaD
Amitriptyline—ADRA2A—Signaling Pathways—PTPN11—peripheral nervous system neoplasm	2.83e-06	4.33e-05	CbGpPWpGaD
Amitriptyline—HRH2—Signaling Pathways—HRAS—peripheral nervous system neoplasm	2.79e-06	4.27e-05	CbGpPWpGaD
Amitriptyline—OPRK1—Signaling Pathways—MYC—peripheral nervous system neoplasm	2.76e-06	4.23e-05	CbGpPWpGaD
Amitriptyline—CHRM4—Signaling Pathways—NRAS—peripheral nervous system neoplasm	2.76e-06	4.22e-05	CbGpPWpGaD
Amitriptyline—OPRM1—Signaling by GPCR—AKT1—peripheral nervous system neoplasm	2.74e-06	4.2e-05	CbGpPWpGaD
Amitriptyline—HTR6—Signaling Pathways—MYC—peripheral nervous system neoplasm	2.72e-06	4.17e-05	CbGpPWpGaD
Amitriptyline—HTR7—Signaling Pathways—MYC—peripheral nervous system neoplasm	2.72e-06	4.16e-05	CbGpPWpGaD
Amitriptyline—DRD3—Signaling by GPCR—AKT1—peripheral nervous system neoplasm	2.71e-06	4.16e-05	CbGpPWpGaD
Amitriptyline—ADRA1D—Signaling by GPCR—AKT1—peripheral nervous system neoplasm	2.71e-06	4.16e-05	CbGpPWpGaD
Amitriptyline—ADRA1B—Signaling Pathways—ERBB2—peripheral nervous system neoplasm	2.71e-06	4.15e-05	CbGpPWpGaD
Amitriptyline—HTR1D—Signaling Pathways—MYC—peripheral nervous system neoplasm	2.7e-06	4.14e-05	CbGpPWpGaD
Amitriptyline—CYP3A4—Metabolism—BCHE—peripheral nervous system neoplasm	2.7e-06	4.14e-05	CbGpPWpGaD
Amitriptyline—CYP1A2—Metabolism—GNAS—peripheral nervous system neoplasm	2.69e-06	4.11e-05	CbGpPWpGaD
Amitriptyline—HTR1A—Signaling by GPCR—HRAS—peripheral nervous system neoplasm	2.68e-06	4.1e-05	CbGpPWpGaD
Amitriptyline—HTR2C—Signaling by GPCR—HRAS—peripheral nervous system neoplasm	2.67e-06	4.08e-05	CbGpPWpGaD
Amitriptyline—HTR1B—Signaling Pathways—MYC—peripheral nervous system neoplasm	2.65e-06	4.05e-05	CbGpPWpGaD
Amitriptyline—CHRM5—Signaling Pathways—NRAS—peripheral nervous system neoplasm	2.64e-06	4.04e-05	CbGpPWpGaD
Amitriptyline—CYP1A2—Metabolism—ABCB1—peripheral nervous system neoplasm	2.64e-06	4.04e-05	CbGpPWpGaD
Amitriptyline—HTR1A—GPCR downstream signaling—AKT1—peripheral nervous system neoplasm	2.61e-06	3.99e-05	CbGpPWpGaD
Amitriptyline—HTR2C—GPCR downstream signaling—AKT1—peripheral nervous system neoplasm	2.59e-06	3.97e-05	CbGpPWpGaD
Amitriptyline—OPRD1—Signaling Pathways—TP53—peripheral nervous system neoplasm	2.59e-06	3.96e-05	CbGpPWpGaD
Amitriptyline—HTR1A—Signaling Pathways—CASP3—peripheral nervous system neoplasm	2.58e-06	3.95e-05	CbGpPWpGaD
Amitriptyline—CYP3A4—Metabolism—SLC2A1—peripheral nervous system neoplasm	2.58e-06	3.95e-05	CbGpPWpGaD
Amitriptyline—CHRM4—Signaling Pathways—MYC—peripheral nervous system neoplasm	2.57e-06	3.93e-05	CbGpPWpGaD
Amitriptyline—HTR2C—Signaling Pathways—CASP3—peripheral nervous system neoplasm	2.57e-06	3.93e-05	CbGpPWpGaD
Amitriptyline—ALB—Hemostasis—AKT1—peripheral nervous system neoplasm	2.56e-06	3.92e-05	CbGpPWpGaD
Amitriptyline—ADRA1B—Signaling by GPCR—HRAS—peripheral nervous system neoplasm	2.55e-06	3.91e-05	CbGpPWpGaD
Amitriptyline—CYP3A4—Metabolism—TH—peripheral nervous system neoplasm	2.54e-06	3.89e-05	CbGpPWpGaD
Amitriptyline—OPRM1—Signaling Pathways—NRAS—peripheral nervous system neoplasm	2.51e-06	3.84e-05	CbGpPWpGaD
Amitriptyline—DRD2—Signaling Pathways—ERBB2—peripheral nervous system neoplasm	2.5e-06	3.82e-05	CbGpPWpGaD
Amitriptyline—DRD3—Signaling Pathways—NRAS—peripheral nervous system neoplasm	2.48e-06	3.8e-05	CbGpPWpGaD
Amitriptyline—ADRA1D—Signaling Pathways—NRAS—peripheral nervous system neoplasm	2.48e-06	3.8e-05	CbGpPWpGaD
Amitriptyline—ADRA1B—GPCR downstream signaling—AKT1—peripheral nervous system neoplasm	2.48e-06	3.8e-05	CbGpPWpGaD
Amitriptyline—OPRD1—Signaling Pathways—HRAS—peripheral nervous system neoplasm	2.47e-06	3.79e-05	CbGpPWpGaD
Amitriptyline—HRH2—Signaling Pathways—AKT1—peripheral nervous system neoplasm	2.46e-06	3.77e-05	CbGpPWpGaD
Amitriptyline—CHRM5—Signaling Pathways—MYC—peripheral nervous system neoplasm	2.46e-06	3.77e-05	CbGpPWpGaD
Amitriptyline—ADRA1B—Signaling Pathways—CASP3—peripheral nervous system neoplasm	2.46e-06	3.76e-05	CbGpPWpGaD
Amitriptyline—HTR2A—Signaling Pathways—ERBB2—peripheral nervous system neoplasm	2.46e-06	3.76e-05	CbGpPWpGaD
Amitriptyline—HRH1—Signaling Pathways—ERBB2—peripheral nervous system neoplasm	2.45e-06	3.75e-05	CbGpPWpGaD
Amitriptyline—CHRM1—Signaling Pathways—ERBB2—peripheral nervous system neoplasm	2.44e-06	3.74e-05	CbGpPWpGaD
Amitriptyline—CHRM3—Signaling Pathways—ERBB2—peripheral nervous system neoplasm	2.44e-06	3.73e-05	CbGpPWpGaD
Amitriptyline—CHRM2—Signaling Pathways—ERBB2—peripheral nervous system neoplasm	2.41e-06	3.69e-05	CbGpPWpGaD
Amitriptyline—ADRA1A—Signaling Pathways—ERBB2—peripheral nervous system neoplasm	2.41e-06	3.68e-05	CbGpPWpGaD
Amitriptyline—HTR1A—Signaling by GPCR—AKT1—peripheral nervous system neoplasm	2.37e-06	3.62e-05	CbGpPWpGaD
Amitriptyline—HTR2C—Signaling by GPCR—AKT1—peripheral nervous system neoplasm	2.35e-06	3.6e-05	CbGpPWpGaD
Amitriptyline—DRD2—Signaling by GPCR—HRAS—peripheral nervous system neoplasm	2.35e-06	3.6e-05	CbGpPWpGaD
Amitriptyline—OPRM1—Signaling Pathways—MYC—peripheral nervous system neoplasm	2.33e-06	3.58e-05	CbGpPWpGaD
Amitriptyline—HTR2A—Signaling by GPCR—HRAS—peripheral nervous system neoplasm	2.31e-06	3.54e-05	CbGpPWpGaD
Amitriptyline—ADRA1D—Signaling Pathways—MYC—peripheral nervous system neoplasm	2.31e-06	3.54e-05	CbGpPWpGaD
Amitriptyline—DRD3—Signaling Pathways—MYC—peripheral nervous system neoplasm	2.31e-06	3.54e-05	CbGpPWpGaD
Amitriptyline—HRH1—Signaling by GPCR—HRAS—peripheral nervous system neoplasm	2.31e-06	3.54e-05	CbGpPWpGaD
Amitriptyline—CHRM1—Signaling by GPCR—HRAS—peripheral nervous system neoplasm	2.3e-06	3.53e-05	CbGpPWpGaD
Amitriptyline—CHRM3—Signaling by GPCR—HRAS—peripheral nervous system neoplasm	2.3e-06	3.51e-05	CbGpPWpGaD
Amitriptyline—DRD2—GPCR downstream signaling—AKT1—peripheral nervous system neoplasm	2.29e-06	3.5e-05	CbGpPWpGaD
Amitriptyline—CHRM2—Signaling by GPCR—HRAS—peripheral nervous system neoplasm	2.27e-06	3.48e-05	CbGpPWpGaD
Amitriptyline—OPRK1—Signaling Pathways—TP53—peripheral nervous system neoplasm	2.27e-06	3.47e-05	CbGpPWpGaD
Amitriptyline—ADRA1A—Signaling by GPCR—HRAS—peripheral nervous system neoplasm	2.27e-06	3.47e-05	CbGpPWpGaD
Amitriptyline—DRD2—Signaling Pathways—CASP3—peripheral nervous system neoplasm	2.27e-06	3.47e-05	CbGpPWpGaD
Amitriptyline—ADRA1B—Signaling by GPCR—AKT1—peripheral nervous system neoplasm	2.25e-06	3.45e-05	CbGpPWpGaD
Amitriptyline—HTR2A—GPCR downstream signaling—AKT1—peripheral nervous system neoplasm	2.25e-06	3.45e-05	CbGpPWpGaD
Amitriptyline—HRH1—GPCR downstream signaling—AKT1—peripheral nervous system neoplasm	2.25e-06	3.44e-05	CbGpPWpGaD
Amitriptyline—CHRM1—GPCR downstream signaling—AKT1—peripheral nervous system neoplasm	2.24e-06	3.43e-05	CbGpPWpGaD
Amitriptyline—HTR6—Signaling Pathways—TP53—peripheral nervous system neoplasm	2.24e-06	3.42e-05	CbGpPWpGaD
Amitriptyline—ADRA2A—Signaling Pathways—ERBB2—peripheral nervous system neoplasm	2.24e-06	3.42e-05	CbGpPWpGaD
Amitriptyline—HTR7—Signaling Pathways—TP53—peripheral nervous system neoplasm	2.23e-06	3.42e-05	CbGpPWpGaD
Amitriptyline—CHRM3—GPCR downstream signaling—AKT1—peripheral nervous system neoplasm	2.23e-06	3.42e-05	CbGpPWpGaD
Amitriptyline—HTR2A—Signaling Pathways—CASP3—peripheral nervous system neoplasm	2.23e-06	3.41e-05	CbGpPWpGaD
Amitriptyline—HRH1—Signaling Pathways—CASP3—peripheral nervous system neoplasm	2.23e-06	3.41e-05	CbGpPWpGaD
Amitriptyline—HTR1D—Signaling Pathways—TP53—peripheral nervous system neoplasm	2.22e-06	3.4e-05	CbGpPWpGaD
Amitriptyline—CHRM1—Signaling Pathways—CASP3—peripheral nervous system neoplasm	2.22e-06	3.4e-05	CbGpPWpGaD
Amitriptyline—CHRM3—Signaling Pathways—CASP3—peripheral nervous system neoplasm	2.21e-06	3.39e-05	CbGpPWpGaD
Amitriptyline—CHRM2—GPCR downstream signaling—AKT1—peripheral nervous system neoplasm	2.21e-06	3.38e-05	CbGpPWpGaD
Amitriptyline—ADRA1A—GPCR downstream signaling—AKT1—peripheral nervous system neoplasm	2.2e-06	3.37e-05	CbGpPWpGaD
Amitriptyline—CHRM2—Signaling Pathways—CASP3—peripheral nervous system neoplasm	2.19e-06	3.35e-05	CbGpPWpGaD
Amitriptyline—OPRD1—Signaling Pathways—AKT1—peripheral nervous system neoplasm	2.18e-06	3.35e-05	CbGpPWpGaD
Amitriptyline—ADRA1A—Signaling Pathways—CASP3—peripheral nervous system neoplasm	2.18e-06	3.34e-05	CbGpPWpGaD
Amitriptyline—HTR1B—Signaling Pathways—TP53—peripheral nervous system neoplasm	2.17e-06	3.33e-05	CbGpPWpGaD
Amitriptyline—OPRK1—Signaling Pathways—HRAS—peripheral nervous system neoplasm	2.17e-06	3.32e-05	CbGpPWpGaD
Amitriptyline—HTR1A—Signaling Pathways—NRAS—peripheral nervous system neoplasm	2.16e-06	3.31e-05	CbGpPWpGaD
Amitriptyline—HTR2C—Signaling Pathways—NRAS—peripheral nervous system neoplasm	2.15e-06	3.3e-05	CbGpPWpGaD
Amitriptyline—HTR6—Signaling Pathways—HRAS—peripheral nervous system neoplasm	2.14e-06	3.27e-05	CbGpPWpGaD
Amitriptyline—HTR7—Signaling Pathways—HRAS—peripheral nervous system neoplasm	2.14e-06	3.27e-05	CbGpPWpGaD
Amitriptyline—HTR1D—Signaling Pathways—HRAS—peripheral nervous system neoplasm	2.12e-06	3.25e-05	CbGpPWpGaD
Amitriptyline—CHRM4—Signaling Pathways—TP53—peripheral nervous system neoplasm	2.11e-06	3.23e-05	CbGpPWpGaD
Amitriptyline—ADRA2A—Signaling by GPCR—HRAS—peripheral nervous system neoplasm	2.11e-06	3.22e-05	CbGpPWpGaD
Amitriptyline—HTR1B—Signaling Pathways—HRAS—peripheral nervous system neoplasm	2.08e-06	3.18e-05	CbGpPWpGaD
Amitriptyline—DRD2—Signaling by GPCR—AKT1—peripheral nervous system neoplasm	2.08e-06	3.18e-05	CbGpPWpGaD
Amitriptyline—CYP3A4—Metabolism—GNAS—peripheral nervous system neoplasm	2.07e-06	3.18e-05	CbGpPWpGaD
Amitriptyline—ADRA1B—Signaling Pathways—NRAS—peripheral nervous system neoplasm	2.06e-06	3.16e-05	CbGpPWpGaD
Amitriptyline—ADRA2A—GPCR downstream signaling—AKT1—peripheral nervous system neoplasm	2.05e-06	3.14e-05	CbGpPWpGaD
Amitriptyline—HTR2A—Signaling by GPCR—AKT1—peripheral nervous system neoplasm	2.04e-06	3.13e-05	CbGpPWpGaD
Amitriptyline—HRH1—Signaling by GPCR—AKT1—peripheral nervous system neoplasm	2.04e-06	3.12e-05	CbGpPWpGaD
Amitriptyline—CYP3A4—Metabolism—ABCB1—peripheral nervous system neoplasm	2.03e-06	3.12e-05	CbGpPWpGaD
Amitriptyline—CHRM1—Signaling by GPCR—AKT1—peripheral nervous system neoplasm	2.03e-06	3.11e-05	CbGpPWpGaD
Amitriptyline—ADRA2A—Signaling Pathways—CASP3—peripheral nervous system neoplasm	2.03e-06	3.11e-05	CbGpPWpGaD
Amitriptyline—CHRM3—Signaling by GPCR—AKT1—peripheral nervous system neoplasm	2.03e-06	3.1e-05	CbGpPWpGaD
Amitriptyline—CHRM5—Signaling Pathways—TP53—peripheral nervous system neoplasm	2.02e-06	3.09e-05	CbGpPWpGaD
Amitriptyline—CHRM4—Signaling Pathways—HRAS—peripheral nervous system neoplasm	2.02e-06	3.09e-05	CbGpPWpGaD
Amitriptyline—HTR1A—Signaling Pathways—MYC—peripheral nervous system neoplasm	2.02e-06	3.09e-05	CbGpPWpGaD
Amitriptyline—CHRM2—Signaling by GPCR—AKT1—peripheral nervous system neoplasm	2.01e-06	3.07e-05	CbGpPWpGaD
Amitriptyline—HTR2C—Signaling Pathways—MYC—peripheral nervous system neoplasm	2.01e-06	3.07e-05	CbGpPWpGaD
Amitriptyline—ADRA1A—Signaling by GPCR—AKT1—peripheral nervous system neoplasm	2e-06	3.06e-05	CbGpPWpGaD
Amitriptyline—CHRM5—Signaling Pathways—HRAS—peripheral nervous system neoplasm	1.93e-06	2.96e-05	CbGpPWpGaD
Amitriptyline—ADRA1B—Signaling Pathways—MYC—peripheral nervous system neoplasm	1.92e-06	2.94e-05	CbGpPWpGaD
Amitriptyline—OPRM1—Signaling Pathways—TP53—peripheral nervous system neoplasm	1.92e-06	2.94e-05	CbGpPWpGaD
Amitriptyline—OPRK1—Signaling Pathways—AKT1—peripheral nervous system neoplasm	1.92e-06	2.93e-05	CbGpPWpGaD
Amitriptyline—DRD2—Signaling Pathways—NRAS—peripheral nervous system neoplasm	1.9e-06	2.91e-05	CbGpPWpGaD
Amitriptyline—DRD3—Signaling Pathways—TP53—peripheral nervous system neoplasm	1.9e-06	2.91e-05	CbGpPWpGaD
Amitriptyline—ADRA1D—Signaling Pathways—TP53—peripheral nervous system neoplasm	1.9e-06	2.91e-05	CbGpPWpGaD
Amitriptyline—HTR6—Signaling Pathways—AKT1—peripheral nervous system neoplasm	1.89e-06	2.89e-05	CbGpPWpGaD
Amitriptyline—HTR7—Signaling Pathways—AKT1—peripheral nervous system neoplasm	1.89e-06	2.89e-05	CbGpPWpGaD
Amitriptyline—HTR1D—Signaling Pathways—AKT1—peripheral nervous system neoplasm	1.87e-06	2.87e-05	CbGpPWpGaD
Amitriptyline—HTR2A—Signaling Pathways—NRAS—peripheral nervous system neoplasm	1.87e-06	2.86e-05	CbGpPWpGaD
Amitriptyline—HRH1—Signaling Pathways—NRAS—peripheral nervous system neoplasm	1.87e-06	2.86e-05	CbGpPWpGaD
Amitriptyline—ADRA2A—Signaling by GPCR—AKT1—peripheral nervous system neoplasm	1.86e-06	2.85e-05	CbGpPWpGaD
Amitriptyline—CHRM1—Signaling Pathways—NRAS—peripheral nervous system neoplasm	1.86e-06	2.85e-05	CbGpPWpGaD
Amitriptyline—CHRM3—Signaling Pathways—NRAS—peripheral nervous system neoplasm	1.85e-06	2.84e-05	CbGpPWpGaD
Amitriptyline—CHRM2—Signaling Pathways—NRAS—peripheral nervous system neoplasm	1.84e-06	2.81e-05	CbGpPWpGaD
Amitriptyline—HTR1B—Signaling Pathways—AKT1—peripheral nervous system neoplasm	1.83e-06	2.81e-05	CbGpPWpGaD
Amitriptyline—OPRM1—Signaling Pathways—HRAS—peripheral nervous system neoplasm	1.83e-06	2.81e-05	CbGpPWpGaD
Amitriptyline—ADRA1A—Signaling Pathways—NRAS—peripheral nervous system neoplasm	1.83e-06	2.8e-05	CbGpPWpGaD
Amitriptyline—ADRA1D—Signaling Pathways—HRAS—peripheral nervous system neoplasm	1.82e-06	2.78e-05	CbGpPWpGaD
Amitriptyline—DRD3—Signaling Pathways—HRAS—peripheral nervous system neoplasm	1.82e-06	2.78e-05	CbGpPWpGaD
Amitriptyline—CHRM4—Signaling Pathways—AKT1—peripheral nervous system neoplasm	1.78e-06	2.73e-05	CbGpPWpGaD
Amitriptyline—DRD2—Signaling Pathways—MYC—peripheral nervous system neoplasm	1.77e-06	2.71e-05	CbGpPWpGaD
Amitriptyline—HTR2A—Signaling Pathways—MYC—peripheral nervous system neoplasm	1.74e-06	2.67e-05	CbGpPWpGaD
Amitriptyline—HRH1—Signaling Pathways—MYC—peripheral nervous system neoplasm	1.74e-06	2.66e-05	CbGpPWpGaD
Amitriptyline—CHRM1—Signaling Pathways—MYC—peripheral nervous system neoplasm	1.73e-06	2.65e-05	CbGpPWpGaD
Amitriptyline—CHRM3—Signaling Pathways—MYC—peripheral nervous system neoplasm	1.73e-06	2.64e-05	CbGpPWpGaD
Amitriptyline—CHRM2—Signaling Pathways—MYC—peripheral nervous system neoplasm	1.71e-06	2.62e-05	CbGpPWpGaD
Amitriptyline—CHRM5—Signaling Pathways—AKT1—peripheral nervous system neoplasm	1.71e-06	2.61e-05	CbGpPWpGaD
Amitriptyline—ADRA1A—Signaling Pathways—MYC—peripheral nervous system neoplasm	1.7e-06	2.61e-05	CbGpPWpGaD
Amitriptyline—ADRA2A—Signaling Pathways—NRAS—peripheral nervous system neoplasm	1.7e-06	2.6e-05	CbGpPWpGaD
Amitriptyline—HTR1A—Signaling Pathways—TP53—peripheral nervous system neoplasm	1.66e-06	2.53e-05	CbGpPWpGaD
Amitriptyline—HTR2C—Signaling Pathways—TP53—peripheral nervous system neoplasm	1.65e-06	2.52e-05	CbGpPWpGaD
Amitriptyline—OPRM1—Signaling Pathways—AKT1—peripheral nervous system neoplasm	1.62e-06	2.48e-05	CbGpPWpGaD
Amitriptyline—DRD3—Signaling Pathways—AKT1—peripheral nervous system neoplasm	1.6e-06	2.46e-05	CbGpPWpGaD
Amitriptyline—ADRA1D—Signaling Pathways—AKT1—peripheral nervous system neoplasm	1.6e-06	2.46e-05	CbGpPWpGaD
Amitriptyline—ADRA2A—Signaling Pathways—MYC—peripheral nervous system neoplasm	1.58e-06	2.43e-05	CbGpPWpGaD
Amitriptyline—HTR1A—Signaling Pathways—HRAS—peripheral nervous system neoplasm	1.58e-06	2.42e-05	CbGpPWpGaD
Amitriptyline—ADRA1B—Signaling Pathways—TP53—peripheral nervous system neoplasm	1.58e-06	2.41e-05	CbGpPWpGaD
Amitriptyline—HTR2C—Signaling Pathways—HRAS—peripheral nervous system neoplasm	1.57e-06	2.41e-05	CbGpPWpGaD
Amitriptyline—ADRA1B—Signaling Pathways—HRAS—peripheral nervous system neoplasm	1.51e-06	2.31e-05	CbGpPWpGaD
Amitriptyline—DRD2—Signaling Pathways—TP53—peripheral nervous system neoplasm	1.45e-06	2.23e-05	CbGpPWpGaD
Amitriptyline—CHRM3—Metabolism—AKT1—peripheral nervous system neoplasm	1.43e-06	2.19e-05	CbGpPWpGaD
Amitriptyline—HTR2A—Signaling Pathways—TP53—peripheral nervous system neoplasm	1.43e-06	2.19e-05	CbGpPWpGaD
Amitriptyline—HRH1—Signaling Pathways—TP53—peripheral nervous system neoplasm	1.43e-06	2.18e-05	CbGpPWpGaD
Amitriptyline—CHRM1—Signaling Pathways—TP53—peripheral nervous system neoplasm	1.42e-06	2.18e-05	CbGpPWpGaD
Amitriptyline—CHRM3—Signaling Pathways—TP53—peripheral nervous system neoplasm	1.42e-06	2.17e-05	CbGpPWpGaD
Amitriptyline—CHRM2—Signaling Pathways—TP53—peripheral nervous system neoplasm	1.4e-06	2.15e-05	CbGpPWpGaD
Amitriptyline—ADRA1A—Signaling Pathways—TP53—peripheral nervous system neoplasm	1.4e-06	2.14e-05	CbGpPWpGaD
Amitriptyline—HTR1A—Signaling Pathways—AKT1—peripheral nervous system neoplasm	1.4e-06	2.14e-05	CbGpPWpGaD
Amitriptyline—HTR2C—Signaling Pathways—AKT1—peripheral nervous system neoplasm	1.39e-06	2.13e-05	CbGpPWpGaD
Amitriptyline—DRD2—Signaling Pathways—HRAS—peripheral nervous system neoplasm	1.39e-06	2.13e-05	CbGpPWpGaD
Amitriptyline—HTR2A—Signaling Pathways—HRAS—peripheral nervous system neoplasm	1.37e-06	2.09e-05	CbGpPWpGaD
Amitriptyline—HRH1—Signaling Pathways—HRAS—peripheral nervous system neoplasm	1.36e-06	2.09e-05	CbGpPWpGaD
Amitriptyline—CHRM1—Signaling Pathways—HRAS—peripheral nervous system neoplasm	1.36e-06	2.08e-05	CbGpPWpGaD
Amitriptyline—CHRM3—Signaling Pathways—HRAS—peripheral nervous system neoplasm	1.36e-06	2.08e-05	CbGpPWpGaD
Amitriptyline—CHRM2—Signaling Pathways—HRAS—peripheral nervous system neoplasm	1.34e-06	2.06e-05	CbGpPWpGaD
Amitriptyline—ADRA1A—Signaling Pathways—HRAS—peripheral nervous system neoplasm	1.34e-06	2.05e-05	CbGpPWpGaD
Amitriptyline—ADRA1B—Signaling Pathways—AKT1—peripheral nervous system neoplasm	1.33e-06	2.04e-05	CbGpPWpGaD
Amitriptyline—ADRA2A—Metabolism—AKT1—peripheral nervous system neoplasm	1.31e-06	2.01e-05	CbGpPWpGaD
Amitriptyline—ADRA2A—Signaling Pathways—TP53—peripheral nervous system neoplasm	1.3e-06	1.99e-05	CbGpPWpGaD
Amitriptyline—ADRA2A—Signaling Pathways—HRAS—peripheral nervous system neoplasm	1.24e-06	1.9e-05	CbGpPWpGaD
Amitriptyline—CYP2B6—Metabolism—AKT1—peripheral nervous system neoplasm	1.23e-06	1.89e-05	CbGpPWpGaD
Amitriptyline—DRD2—Signaling Pathways—AKT1—peripheral nervous system neoplasm	1.23e-06	1.88e-05	CbGpPWpGaD
Amitriptyline—HTR2A—Signaling Pathways—AKT1—peripheral nervous system neoplasm	1.21e-06	1.85e-05	CbGpPWpGaD
Amitriptyline—CYP2E1—Metabolism—AKT1—peripheral nervous system neoplasm	1.21e-06	1.85e-05	CbGpPWpGaD
Amitriptyline—HRH1—Signaling Pathways—AKT1—peripheral nervous system neoplasm	1.2e-06	1.84e-05	CbGpPWpGaD
Amitriptyline—CYP3A5—Metabolism—AKT1—peripheral nervous system neoplasm	1.2e-06	1.84e-05	CbGpPWpGaD
Amitriptyline—CHRM1—Signaling Pathways—AKT1—peripheral nervous system neoplasm	1.2e-06	1.84e-05	CbGpPWpGaD
Amitriptyline—CHRM3—Signaling Pathways—AKT1—peripheral nervous system neoplasm	1.2e-06	1.83e-05	CbGpPWpGaD
Amitriptyline—CHRM2—Signaling Pathways—AKT1—peripheral nervous system neoplasm	1.19e-06	1.82e-05	CbGpPWpGaD
Amitriptyline—ADRA1A—Signaling Pathways—AKT1—peripheral nervous system neoplasm	1.18e-06	1.81e-05	CbGpPWpGaD
Amitriptyline—ADRA2A—Signaling Pathways—AKT1—peripheral nervous system neoplasm	1.1e-06	1.68e-05	CbGpPWpGaD
Amitriptyline—CYP2C8—Metabolism—AKT1—peripheral nervous system neoplasm	1.04e-06	1.6e-05	CbGpPWpGaD
Amitriptyline—ALB—Metabolism—AKT1—peripheral nervous system neoplasm	1.04e-06	1.59e-05	CbGpPWpGaD
Amitriptyline—CYP2C19—Metabolism—AKT1—peripheral nervous system neoplasm	9.31e-07	1.43e-05	CbGpPWpGaD
Amitriptyline—ABCB1—Metabolism—AKT1—peripheral nervous system neoplasm	9.08e-07	1.39e-05	CbGpPWpGaD
Amitriptyline—CYP2D6—Metabolism—AKT1—peripheral nervous system neoplasm	8.56e-07	1.31e-05	CbGpPWpGaD
Amitriptyline—CYP2C9—Metabolism—AKT1—peripheral nervous system neoplasm	8.49e-07	1.3e-05	CbGpPWpGaD
Amitriptyline—CYP1A2—Metabolism—AKT1—peripheral nervous system neoplasm	7.25e-07	1.11e-05	CbGpPWpGaD
Amitriptyline—CYP3A4—Metabolism—AKT1—peripheral nervous system neoplasm	5.6e-07	8.57e-06	CbGpPWpGaD
